Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy LHC Group stock | 210.71

Own LHC Group stock in just a few minutes.

Posted

Fact checked

LHC Group, Inc is a medical care facilities business based in the US. LHC Group shares (LHCG) are listed on the NASDAQ and all prices are listed in US Dollars. LHC Group employs 32,000 staff and has a trailing 12-month revenue of around USD$2.1 billion.

How to buy shares in LHC Group

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for LHC Group. Find the stock by name or ticker symbol: LHCG. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until LHC Group reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$210.71, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of LHC Group, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of LHC Group. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted LHC Group's share price?

Since the stock market crash in March caused by coronavirus, LHC Group's share price has had significant positive movement.

Its last market close was USD$210.71, which is 26.44% up on its pre-crash value of USD$155 and 110.71% up on the lowest point reached during the March crash when the shares fell as low as USD$100.

If you had bought USD$1,000 worth of LHC Group shares at the start of February 2020, those shares would have been worth USD$822.60 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,432.83.

LHC Group share price

Use our graph to track the performance of LHCG stocks over time.

LHC Group shares at a glance

Information last updated 2020-11-26.
Latest market close USD$210.71
52-week range USD$100 - USD$236.81
50-day moving average USD$216.9067
200-day moving average USD$193.4856
Wall St. target price USD$248
PE ratio 61.9848
Dividend yield N/A (0%)
Earnings per share (TTM) USD$3.29

Buy LHC Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy LHC Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

LHC Group price performance over time

Historical closes compared with the close of $210.71 from 2020-11-16

1 week (2020-11-20) 3.21%
1 month (2020-10-30) -2.70%
3 months (2020-08-28) 2.45%
6 months (2020-05-29) 29.66%
1 year (2019-11-29) 57.95%
2 years (2018-11-29) 100.70%
3 years (2017-11-29) 216.81%
5 years (2015-11-27) 345.57%

Is LHC Group under- or over-valued?

Valuing LHC Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LHC Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LHC Group's P/E ratio

LHC Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 62x. In other words, LHC Group shares trade at around 62x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

LHC Group's PEG ratio

LHC Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.328. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LHC Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LHC Group's EBITDA

LHC Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$181.5 million.

The EBITDA is a measure of a LHC Group's overall financial performance and is widely used to measure a its profitability.

LHC Group financials

Revenue TTM USD$2.1 billion
Operating margin TTM 7.78%
Gross profit TTM USD$755.4 million
Return on assets TTM 4.4%
Return on equity TTM 8.16%
Profit margin 5%
Book value $48.003
Market capitalisation USD$6.2 billion

TTM: trailing 12 months

Shorting LHC Group shares

There are currently 617,013 LHC Group shares held short by investors – that's known as LHC Group's "short interest". This figure is 23.4% down from 805,815 last month.

There are a few different ways that this level of interest in shorting LHC Group shares can be evaluated.

LHC Group's "short interest ratio" (SIR)

LHC Group's "short interest ratio" (SIR) is the quantity of LHC Group shares currently shorted divided by the average quantity of LHC Group shares traded daily (recently around 142827.08333333). LHC Group's SIR currently stands at 4.32. In other words for every 100,000 LHC Group shares traded daily on the market, roughly 4320 shares are currently held short.

However LHC Group's short interest can also be evaluated against the total number of LHC Group shares, or, against the total number of tradable LHC Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LHC Group's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 LHC Group shares in existence, roughly 20 shares are currently held short) or 0.0252% of the tradable shares (for every 100,000 tradable LHC Group shares, roughly 25 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against LHC Group.

Find out more about how you can short LHC Group stock.

LHC Group share dividends

We're not expecting LHC Group to pay a dividend over the next 12 months.

LHC Group share price volatility

Over the last 12 months, LHC Group's shares have ranged in value from as little as $100 up to $236.81. A popular way to gauge a stock's volatility is its "beta".

LHCG.US volatility(beta: 0.61)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LHC Group's is 0.6127. This would suggest that LHC Group's shares are less volatile than average (for this exchange).

LHC Group overview

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy, a family health center, a rural health clinic, and a retail pharmacy, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to Accountable Care Organizations. As of December 31, 2019, it operated 553 home health services locations, 110 hospice locations, 107 community-based service locations, 11 long-term acute care hospitals with 13 locations, and 10 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site